- Home
- PLX vs AFCG Comparison
PLX vs AFCG Comparison
Compare PLX & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- AFCG
- Stock Information
- Founded
- PLX 1993
- AFCG 2020
- Country
- PLX United States
- AFCG United States
- Employees
- PLX N/A
- AFCG N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- AFCG Real Estate Investment Trusts
- Sector
- PLX Health Care
- AFCG Real Estate
- Exchange
- PLX Nasdaq
- AFCG Nasdaq
- Market Cap
- PLX 122.6M
- AFCG 127.4M
- IPO Year
- PLX 1998
- AFCG 2021
- Fundamental
- Price
- PLX $1.40
- AFCG $4.62
- Analyst Decision
- PLX Strong Buy
- AFCG Buy
- Analyst Count
- PLX 1
- AFCG 7
- Target Price
- PLX $15.00
- AFCG $11.00
- AVG Volume (30 Days)
- PLX 640.7K
- AFCG 228.5K
- Earning Date
- PLX 08-13-2025
- AFCG 08-06-2025
- Dividend Yield
- PLX N/A
- AFCG 22.41%
- EPS Growth
- PLX N/A
- AFCG 84.02
- EPS
- PLX 0.05
- AFCG 0.96
- Revenue
- PLX $59,764,000.00
- AFCG $41,036,509.00
- Revenue This Year
- PLX $65.02
- AFCG N/A
- Revenue Next Year
- PLX $57.34
- AFCG $17.96
- P/E Ratio
- PLX $28.96
- AFCG $5.15
- Revenue Growth
- PLX 0.18
- AFCG N/A
- 52 Week Low
- PLX $0.82
- AFCG $4.32
- 52 Week High
- PLX $3.10
- AFCG $10.88
- Technical
- Relative Strength Index (RSI)
- PLX 30.38
- AFCG 37.15
- Support Level
- PLX $1.52
- AFCG $4.32
- Resistance Level
- PLX $1.65
- AFCG $5.78
- Average True Range (ATR)
- PLX 0.08
- AFCG 0.25
- MACD
- PLX 0.02
- AFCG -0.08
- Stochastic Oscillator
- PLX 17.19
- AFCG 15.75
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.